Susquehanna International Group, LLP Arcellx, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Arcellx, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 42,540 shares of ACLX stock, worth $2.97 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,540
Previous 95,868
55.63%
Holding current value
$2.97 Million
Previous $8.01 Million
59.54%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ACLX
# of Institutions
224Shares Held
45.1MCall Options Held
434KPut Options Held
433K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$305 Million12.7% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$262 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$246 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$243 Million8.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$233 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.06B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...